Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview

被引:88
|
作者
Banerjee, Suvankar [1 ]
Adhikari, Nilanjan [1 ,2 ]
Amin, Sk Abdul [1 ]
Jha, Tarun [1 ]
机构
[1] Jadavpur Univ, Dept Pharmaceut Technol, Nat Sci Lab, Div Med & Pharmaceut Chem, POB 17020, Kolkata 700032, W Bengal, India
[2] ADAMAS Univ, Sch Pharmaceut Technol, Barasat Barrackpore Rd,PO Jagannathpur, Kolkata 700126, W Bengal, India
关键词
Histone deacetylase; HDAC8; Cancer; inhibitor; Structure-activity relationship (SAR); Quantitative structure-activity relationship (QSAR); DE-LANGE-SYNDROME; SUBEROYLANILIDE HYDROXAMIC ACID; ZINC-BINDING GROUP; BIOLOGICAL EVALUATION; PHASE-I; MOLECULAR-MECHANISMS; CRYSTAL-STRUCTURE; ACTIVITY ASSAY; UP-REGULATION; DESIGN;
D O I
10.1016/j.ejmech.2018.12.039
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The histone deacetylases (HDACs) enzymes provided crucial role in transcriptional regulation of cells through deacetylation of nuclear histone proteins. Discoveries related to the HDAC8 enzyme activity signified the importance of HDAC8 isoform in cell proliferation, tumorigenesis, cancer, neuronal disorders, parasitic/viral infections and other epigenetic regulations. The pan-HDAC inhibitors can confront these conditions but have chances to affect epigenetic functions of other HDAC isoforms. Designing of selective HDAC8 inhibitors is a key feature to combat the pathophysiological and diseased conditions involving the HDAC8 activity. This review is concerned about the structural and positional aspects of HDAC8 in the HDAC family. It also covers the contributions of HDAC8 in the pathophysiological conditions, a preliminary discussion about the recent scenario of HDAC8 inhibitors. This review might help to deliver the structural, functional and computational information in order to identify and design potent and selective HDAC8 inhibitors for target specific treatment of diseases involving HDAC8 enzymatic activity. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:214 / 240
页数:27
相关论文
共 50 条
  • [41] The antileishmanial activity of isoforms 6- and 8-selective histone deacetylase inhibitors
    Sodji, Quaovi
    Patil, Vishal
    Jain, Surendra
    Kornacki, James R.
    Mrksich, Milan
    Tekwani, Babu L.
    Oyelere, Adegboyega K.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (20) : 4826 - 4830
  • [42] Selective and nonselective HDAC8 inhibitors: a therapeutic patent review
    Adhikari, Nilanjan
    Amin, Sk Abdul
    Jha, Tarun
    PHARMACEUTICAL PATENT ANALYST, 2018, 7 (06) : 259 - 276
  • [43] Homology Modeling and Molecular Docking Studies on the Selectivity of HDAC1/HDAC8
    Zhang Yuan
    Chen Ya-Dong
    You Qi-Dong
    Zou Li-Yun
    Yang Yan
    ACTA PHYSICO-CHIMICA SINICA, 2010, 26 (06) : 1676 - 1686
  • [44] Discovery of histone deacetylase 8 selective inhibitors
    Tang, Weiping
    Luo, Tuoping
    Greenberg, Edward F.
    Bradner, James E.
    Schreiber, Stuart L.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (09) : 2601 - 2605
  • [45] Hdac8 In Pulmonary Fibrosis
    Saito, S.
    Zhuang, Y.
    Lasky, J. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [46] Novel HDAC8 inhibitors: A multi-computational approach
    Manal, M.
    Manish, K.
    Sanal, D.
    Selvaraj, A.
    Devadasan, V.
    Chandrasekar, M. J. N.
    SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2017, 28 (09) : 707 - 733
  • [47] Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor
    Vannini, A
    Volpari, C
    Filocamo, G
    Casavola, EC
    Brunetti, M
    Renzoni, D
    Chakravarty, P
    Paolini, C
    De Francesco, R
    Gallinari, P
    Steinkühler, C
    Di Marco, S
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (42) : 15064 - 15069
  • [48] Identification of a Novel Aminotetralin Class of HDAC6 and HDAC8 Selective Inhibitors
    Tang, Guozhi
    Wong, Jason C.
    Zhang, Weixing
    Wang, Zhanguo
    Zhang, Nan
    Peng, Zhenghong
    Zhang, Zhenshan
    Rong, Yiping
    Li, Shijie
    Zhang, Meifang
    Yu, Lingjie
    Feng, Teng
    Zhang, Xiongwen
    Wu, Xihan
    Wu, Jim Z.
    Chen, Li
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (19) : 8026 - 8034
  • [49] Isophthalic Acid-Based HDAC Inhibitors as Potent Inhibitors of HDAC8 from Schistosoma mansoni
    Stenzel, Katharina
    Chakrabarti, Alokta
    Melesina, Jelena
    Hansen, Finn K.
    Lancelot, Julien
    Herkenhohner, Simon
    Lungerich, Beate
    Marek, Martin
    Romier, Christophe
    Pierce, Raymond. J.
    Sippl, Wolfgang
    Jung, Manfred
    Kurz, Thomas
    ARCHIV DER PHARMAZIE, 2017, 350 (08)
  • [50] Effects of triptolide on histone acetylation and HDAC8 expression in multiple myeloma in vitro
    Zhao, Fei
    Zeng, Ling-lan
    Chen, Yan
    Li, Rui
    Liu, Yuan
    Wen, Lu
    Cheng, Yi-quan
    Zhang, Chun
    CHINESE JOURNAL OF CANCER RESEARCH, 2010, 22 (02) : 148 - 155